COMMUNIQUÉS West-GlobeNewswire
-
JAMA Study Using Alamar Biosciences’ NULISA Assay Links Blood eMTBR-tau to Tau tangle Burden in Former Football Players with Advanced CTE
20/11/2026 -
Polaryx Therapeutics Highlights Participation in NCL Scientific Conference and NTSAD Imagine & Believe Event
20/11/2026 -
Biotricity Reports Second Quarter Fiscal 2027 Results
20/11/2026 -
MMI Adds Energy Capabilities to the Symani® Surgical System with the Introduction of NanoWrist® Monopolar Scissors
20/11/2026 -
Aprea Therapeutics Announces Interim Results From the Ongoing First-in-human Phase 1 Study of WEE1 Inhibitor APR-1051 in Patients with Advanced Solid Tumors (ACESOT-1051) at the 38th EORTC-NCI-AACR Symposium in Barcelona
20/11/2026 -
Walmart Canada amasse plus de 3,9 millions de dollars au profit des programmes de secours et de préparation aux urgences de la Croix-Rouge canadienne
20/11/2026 -
Canadian Red Cross and Walmart Canada’s annual campaign raises more than $3.9 million for disaster relief and preparedness
20/11/2026 -
Hair Loss Treatment: A Normal Blood Count Does Not Rule Out Iron Deficiency Hair Loss, and Most Treatment Never Orders the Ferritin Test
20/11/2026 -
Protext Mobility, Inc. (OTC: TXTM) Chairman’s Strategic Shareholder Update
20/11/2026 -
NewGenIvf Group Limited Announces Closing of $2.5 Million Underwritten Offering
20/11/2026 -
IBA vend un premier système à rayons X Rhodotron® LITE dans la foulée de son lancement
20/11/2026 -
First Rhodotron® LITE X-ray system sold shortly after launch
20/11/2026 -
ADDEX THERAPEUTICS TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 25, 2026
20/11/2026 -
DXS International Plc (AQSE: DXSP): Result of DXS AGM 2026
20/11/2026 -
Leads Biolabs Presents Opamtistomig (PD-L1/4-1BB Bispecific Antibody) to Global Investors at the 2026 Jefferies Global Healthcare Conference
20/11/2026 -
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Atopic Dermatitis
19/11/2026 -
Kamada Updates on Withholding Tax Procedures on Previously Announced Cash Dividend to Shareholders
19/11/2026 -
Alpha Tau Announces Third Quarter 2026 Financial Results and Provides Corporate Update
19/11/2026 -
Standard BioTools Stockholders Approve All Proposals Related to Merger with Treeline Biosciences and Sale of Mass Cytometry Business
19/11/2026
Pages